YOU are your first advocate. Don’t be afraid to ask your healthcare staff inquiries to be sure you’re doing all the pieces you may to assist scale back your danger of HER2+ breast most cancers recurrence. Speak to your physician at this time and take a stand in opposition to HER2+ breast most cancers recurrence with NERLYNX. NERLYNX is an oral medicine taken for 1-year after trastuzumab-based remedy which will assist to cut back your danger of HER2+ breast most cancers.
NERLYNX may cause uncomfortable side effects, together with diarrhea which might be critical.
Please see Necessary Security Info: https://nerlynx.com/
Affected person Info: https://nerlynx.com/pdf/nerlynx_product_information_download.pdf
